We are edging closer to a nationwide return to in-person learning in the fall. However, vaccinations alone will not get us through this. Young children not being able to vaccinate, the spread of new and more contagious variants, and questions about the longevity of vaccines are all factors that will complicate the safe reopening of schools. Until vaccines are authorized for children of all ages, rapid antigen testing is one alternative to detect the virus, which will help limit outbreaks and keep schools open consistently.
BD is hosting a virtual roundtable discussing the benefits of asymptomatic screening of COVID-19 using rapid antigen serial testing. Featuring a panel of school and health officials, this webinar will share best practices on how to set up an effective and efficient process for testing in schools.
